Literature DB >> 401327

Teratomas, neoplasia and differentiation: a biological overview. I. The natural history of teratomas.

M J O'Hare1.   

Abstract

In this paper I have attempted to outline the natural history of spontaneously occurring teratomas and associated tumours, but without introducing any preconceptions or assumptions as to their histogenesis or mechanisms of internal differentiation. The justification for this omission is that there is presently no direct evidence in respect of either process in human tumours of this type, with the exception of recent work by LINDER et al. (1975a, b). The various histopathological classifications of teratoid lesions have not been discussed in detail either, because for the most part they have been evolved to serve a specific prognostic purpose on either an empirical basis or on certain histogenetic assumptions. In either case there is an inevitable tendency to emphasize extremes of morphological appearance at the expense of possible continuities of structure and behaviour across the spectrum of teratoid lesions. The purpose of this paper, on the contrary, has been to discern features common to these tumours whenever and wherever they occur. Thus, human teratomas are uniquely puritissular lesions composed, potentially at least, of virtually every recognizable (and probably some as yet unrecognizable), type of embryonic, foetal and adult cell and tissue, together with, in some cases, frankly malignant cells of no obvious derivation or differentiation. In spite of the occasional appearance of structures resembling pre-somite embryos (embryoid bodies), there is no compelling evidence that human teratomatous histogenesis recapitulates embryogenesis in any strict fashion. Histologically, the overwhelming impression is of a more or less random association of cells and tissues at different stages of development and differentiation that proceed up to but not beyond organogenesis. Such teratomas are found at a number of well-defined sites, of which the sacrococcyx is the most prominent in infancy and the gonads during adult life. Both gonadal and extragonadal sites are also associated with apparently homogeneous neoplasms containing cells with features reminiscent of early stages of germinal differentiation which evoke, in many cases, a marked stromal and lymphocytic response, the so-called germinomas. In 'mixed' tumours, which are recognized in an increasing proportion of cases, there is karyological evidence of a conjoint rather than separate origin of teratomatous and germinomatous elements in at least some tumours, challenging a long held belief in their invariably separate character (e.g. HALLEY, 1963).

Entities:  

Mesh:

Year:  1978        PMID: 401327

Source DB:  PubMed          Journal:  Invest Cell Pathol        ISSN: 0146-7611


  6 in total

Review 1.  Somatic stem cells and the origin of cancer.

Authors:  José A Martínez-Climent; Enrique J Andreu; Felipe Prosper
Journal:  Clin Transl Oncol       Date:  2006-09       Impact factor: 3.405

2.  Tumor stem cells: A new approach for tumor therapy (Review).

Authors:  Min Meng; Xin-Han Zhao; Qian Ning; Lei Hou; Guo-Hong Xin; Li-Feng Liu
Journal:  Oncol Lett       Date:  2012-05-25       Impact factor: 2.967

3.  Germ cell tumours of childhood: a review of 137 cases.

Authors:  H B Marsden; J M Birch; R Swindell
Journal:  J Clin Pathol       Date:  1981-08       Impact factor: 3.411

Review 4.  Cellular origin of cancer: dedifferentiation or stem cell maturation arrest?

Authors:  S Sell
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

5.  The effects of regional factors on the growth rate and the differentiation of mouse teratocarcinoma.

Authors:  J W Oosterhuis; O Bagasra; H Kushner; N Fox; I Damjanov
Journal:  Br J Cancer       Date:  1983-03       Impact factor: 7.640

6.  Contributions of ibadan to the development of pathology in the tropics: inaugural lecture delivered on 27 july 2006 faculty of education lecture Hall, university of ibadan.

Authors:  Eeu Akang
Journal:  Ann Ib Postgrad Med       Date:  2010-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.